Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings

Shares (Q2 2026)
399
Value
$6.78K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TBPH by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026399$6.78K<0.1%+31+8.4%AddedHolders
Q1 2026368$5.97K<0.1%−47−11.3%ReducedHolders
Q4 2025415$7.76K<0.1%+47+12.8%AddedHolders
Q3 2025368$5.37K<0.1%+9+2.5%AddedHolders
Q2 2025359$3.96K<0.1%−146−28.9%ReducedHolders
Q1 2025505$4.51K<0.1%+146+40.7%AddedHolders
Q4 2024359$3.38K<0.1%+359NewHolders
Q3 20240$00.0%−285−100.0%Sold outHolders
Q2 2024285$2.42K<0.1%−223−43.9%ReducedHolders
Q1 2024508$4.56K<0.1%−926−64.6%ReducedHolders
Q4 20231,434$16.1K<0.1%+434+43.4%AddedHolders
Q3 20231,000$8.63K<0.1%−134−11.8%ReducedHolders
Q2 20231,134$11.7K<0.1%−940−45.3%ReducedHolders
Q1 20232,074$22.5K<0.1%+305+17.2%AddedHolders
Q4 20221,769$19.8K<0.1%00.0%UnchangedHolders
Q3 20221,769$18.0K<0.1%−779−30.6%ReducedHolders
Q2 20222,548$23.0K<0.1%−29−1.1%ReducedHolders
Q1 20222,577$25.0K<0.1%+4+0.2%AddedHolders
Q4 20212,573$28.0K<0.1%+2,424+1,626.8%AddedHolders
Q3 2021149$1.00K<0.1%+109+272.5%AddedHolders
Q2 202140$1.00K<0.1%00.0%UnchangedHolders
Q1 202140$1.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.